The marked reduction in cytokeratin levels following PROS1 knockdown supports the pathological assessment, and together with reduced tumor growth in-vivo indicate decreased malignancy of OSCC tumors following PROS1 knockdown. This evidence concerns the gene PROS1 and neoplasm.